Clinical trials: CD34 Selected Peripheral Blood Stem Cell Graft, active
Bone Marrow Failure Syndrome, Severe Aplastic Anemia
CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation
This study's goal is to determine the frequency and severity of acute graft versus host disease, to evaluate incidence of primary and secondary graft rejection, to assess event free survival and overall survival, to determine the…
- Conditions
- Bone Marrow Failure Syndrome, Severe Aplastic Anemia, Severe Congenital Neutropenia, Amegakaryocytic Thrombocytopenia
- Trial name
- NCT01966367
- Testing
- CD34 Stem Cell Selection Therapy
- Where
- United States
- Volunteers
- 37 people
- Sponsor
- Diane George
Blood And Marrow Transplantation
Compassionate Access of the Miltenyi Device for CD34+ Cell Selection
Objectives: Primary Objective To provide compassionate access to the Miltenyi device for CD34+ cell infusions to patients who experience poor graft function after stem cell transplantation (SCT).
- Trial name
- NCT02438904
- Testing
- CD34 Positive Stem Cell Infusion, Miltenyi device
- Where
- United States
- Volunteers
- 200 people
- Sponsor
- M.D. Anderson Cancer Center